Tuesday 31st January 2012
|Text too small?|
Mondrian Investment Partners, a fund manager whose mandates include a share of the UK's Pension Protection Fund, sold down its stake in Fisher & Paykel Healthcare in the biggest transaction in the stock for 15 months.
The fund manager based in London and Philadelphia sold 7.66 million shares, or about 1.4 percent of F&P Healthcare, reducing its holding to 4.1 percent from 6.08 percent, it said in a notice to the NZX.
Shares of the company have shed about a third of their value in the past 12 months and closed yesterday at $2.18, down from $3.18 a year ago. The stock is rated ‘outperform’ based on the consensus of nine analysts polled by Reuters with a price target of $2.75.
Mondrian has some US$65 billion under management, according to its website. Of that, 45 percent is invested in equities in developed markets.
No comments yet
NZ dollar rally may limit profit gains for Fisher and Paykel Healthcare, brokerage says
FISHER & PAYKEL HEALTHCARE ANNOUNCES NEW NASAL PILLOWS MASK AT INVESTOR DAY
Shares in Fisher and Paykel Healthcare third-best performer on NZX 50 after raising earnings forecast
Fisher and Paykel Healthcare raises 2014 earnings forecast on higher sales, margins
F and P Healthcare shares jump to highest in more than 2 years on profit outlook
F and P Healthcare beats 2013 guidance, forecasts boost in 2014 profit; shares gain to 2 1/2 year high
F and P Healthcare shares rise to two-year high as First NZ raises rating on better outlook
Fisher & Paykel Healthcare
F and P Healthcare lifts guidance as sales grow, margins widen; shares rally
F&P Healthcare 1H profit rises 18%, on record sales, wider margins